EGFR and non-small cell lung carcinoma: Thus, the FePt-Cys NPs have the potential to act as a sensitizer for chemo-radiotherapy.572 Reda et al. developed a novel PLK1 and EGFR-targeted nanomaterial, which emerged as a finely targeted therapy and enhanced radiation sensitivity in NSCLC.592 In another study, Sanche et al. indicated that Au nanomaterials have the potential to act as proficient sensitizers in cisplatin when exposed to X-ray radiation.